Market Cap

Newron Pharmaceuticals SpA Market Capitalization:

€526.0 Million

EUR as of Jan. 1, 2026

US$617.7 Million

business Newron Pharmaceuticals SpA Company Profile

Newron Pharmaceuticals SpA Main Stock Listing

XETR: NP5

Market Capitalization History of Newron Pharmaceuticals SpA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Newron Pharmaceuticals SpA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €526.0 M 183.54%
Jan. 1, 2025 €185.5 M 56.32%
Jan. 1, 2024 €118.7 M 168.15%
Jan. 1, 2023 €44.3 M 81.55%
Jan. 1, 2022 €24.4 M -49.41%
Jan. 1, 2021 €48.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Newron Pharmaceuticals SpA Categories

Italy languages Healthcare languages Biotechnology
Italy Healthcare Italy Biotechnology

Stocks & Indices

Newron Pharmaceuticals SpA has the following listings and related stock indices.


Stock: XETR: NP5

Stock: FSX: NP5

Stock: OTC: NWPHF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.